Success Metrics

Clinical Success Rate
67.6%

Based on 23 completed trials

Completion Rate
68%(23/34)
Active Trials
7(12%)
Results Posted
65%(15 trials)
Terminated
11(18%)

Phase Distribution

Ph phase_2
18
30%
Ph not_applicable
10
17%
Ph phase_1
10
17%
Ph phase_3
8
13%
Ph early_phase_1
1
2%
Ph phase_4
13
22%

Phase Distribution

11

Early Stage

18

Mid Stage

21

Late Stage

Phase Distribution60 total trials
Early Phase 1First-in-human
1(1.7%)
Phase 1Safety & dosage
10(16.7%)
Phase 2Efficacy & side effects
18(30.0%)
Phase 3Large-scale testing
8(13.3%)
Phase 4Post-market surveillance
13(21.7%)
N/ANon-phased studies
10(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.2%

23 of 37 finished

Non-Completion Rate

37.8%

14 ended early

Currently Active

7

trials recruiting

Total Trials

60

all time

Status Distribution
Active(13)
Completed(23)
Terminated(14)
Other(10)

Detailed Status

Completed23
Terminated11
unknown8
Not yet recruiting6
Recruiting5
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
60
Active
7
Success Rate
67.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.7%)
Phase 110 (16.7%)
Phase 218 (30.0%)
Phase 38 (13.3%)
Phase 413 (21.7%)
N/A10 (16.7%)

Trials by Status

active_not_recruiting23%
recruiting58%
suspended23%
completed2338%
terminated1118%
not_yet_recruiting610%
unknown813%
withdrawn35%

Recent Activity

Clinical Trials (60)

Showing 20 of 60 trialsScroll for more
NCT04512287Phase 2

PRP for Treatment of Peyronie's Disease

Completed
NCT07709494Phase 1

A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa

Recruiting
NCT07718126Phase 2

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

Not Yet Recruiting
NCT07715045Phase 2

Umbilical Cord Mesenchymal Stromal Cell Secretome for Moderate Rheumatoid Arthritis: A Randomized Double-Blind Placebo-Controlled Trial

Completed
NCT06855758Not Applicable

Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation

Active Not Recruiting
NCT07202000Phase 2

EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC)

Recruiting
NCT07686692Phase 4

IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency

Not Yet Recruiting
NCT07583745Phase 2

Study of EPN-701 for the Treatment of Calciphylaxis

Not Yet Recruiting
NCT07655180Phase 3

Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

Recruiting
NCT07617155Phase 4

GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis

Not Yet Recruiting
NCT07280858Phase 1

A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.

Recruiting
NCT07158437Phase 1

Phase 1 Study of SL-325 in Healthy Volunteers

Active Not Recruiting
NCT07460518Phase 4

Tranexamic Acid for Bleeding Reduction During TURP Surgery

Not Yet Recruiting
NCT07421817Not Applicable

Dexamethasone for Prevention of Postoperative Vomiting After Laparoscopic Gynecologic Surgery

Completed
NCT07237880Not Applicable

Use of Papaverine to Shorten the Second Stage/Duration of Labor in Pregnant Women After Cervical Ripening by Double-balloon Catheter

Recruiting
NCT05012943Phase 2

The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01)

Completed
NCT07146087Early Phase 1

Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis

Suspended
NCT04876937Not Applicable

Low-Dose Dexmedetomidine for Delirium Prevention in Mechanically Ventilated Septic Patients

Terminated
NCT03172897Phase 4

Low-dose Dexmedetomidine in Mechanically Ventilated ICU Patients

Suspended
NCT06886230Phase 4

Ondansetron vs. Dexamethasone for Postoperative Nausea

Completed

Drug Details

Intervention Type
OTHER
Total Trials
60